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Although profoundly studied, etiology of pancreatic cancer (PC) is still rather scant. Exposure to cadmium (Cd), a ubiquitous
metal associated with well-established toxic and carcinogenic properties, has been hypothesized to one putative cause of PC. Hence,
we analyzed recently published observational studies, meta-analyses, and experimental animal and in vitro studies with the aim
of summarizing the evidence of Cd involvement in PC development and describing the possible mechanisms. Consolidation of
epidemiological data on PC and exposure to Cd indicated a significant association with an elevated risk of PC among general
population exposed to Cd. Cadmium exposure of laboratory animals was showed to cause PC supporting the findings suggested
by human studies. The concordance with human and animal studies is buttressed by in vitro studies, although in vitro data
interpretation is problematic. In most instances, only significant effects are reported, and the concentrations of Cd are excessive,
which would skew interpretation. Previous reports suggest that oxidative stress, apoptotic changes, and DNA cross-linking and
hypermethylation are involved in Cd-mediated carcinogenesis. Undoubtedly, a significant amount of work is still needed to achieve
a better understanding of the Cd involvement in pancreatic cancer which could facilitate prevention, diagnosis, and therapy of this
fatal disease.
1. Introduction
Pancreatic cancer (PC) is one of the most lethal human can-
cers and an important cause of cancer-associated-mortalities
worldwide [1, 2]. With no specific symptoms observed until
in its advanced and incurable stage, PC develops insidiously
and at the time of diagnosis majority of patients already
faces an advanced form of the disease. Thus, PC has the
worst survival rate of any major cancer, and its mortality has
been gradually increasing over the past decades. Profound
studies have been undertaken with the aim of improving our
understanding of this aggressive disease, and while certain
advances in molecular biology have greatly enhanced the
understanding of PC pathogenesis, the etiology remains
rather elusive. Some genetic risk factors have been identified,
such as mutations of K-ras oncogene and various suppressor
genes but they account for less than 10% of all PC causes [3].
The main nongenetic environmental factors that have been
associated with PC initiation so far are inhalation of cigarette
smoke, exposure to mutagenic nitrosamines, chlorinated
hydrocarbon solvents, and heavy metals [4].
Among different heavy metals, attention must be given
to involuntary human exposure to cadmium (Cd). This toxic
element is currently one of the most abundant occupational
and environmental pollutants; it is present in the diet, tobacco
smoking, air, soil, and water [5]. Although the production of
Cd has declined, its persistence and long biological half-life
have led to the increase of health risks this metal impose [5].
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Numerous studies have confirmed its toxic effects on many
organs systems and this toxicity is dependent on dose, route,
and duration of exposure. Cd has been shown to produce
damage to the lung, liver, kidney, bones, and testes [5–7].
Novel investigations point to its endocrine disrupting prop-
erties suggesting Cd role in diabetes mellitus [8], different
types of thyroid disruption [9, 10], and its estrogenic activity
[11, 12]. Cadmium and its compounds have been classified as
known human carcinogens by the International Agency for
Research on Cancer since 1993 [13] based on epidemiological
studies showing a causal connection with the development
of lung cancer. Epidemiological studies have also implicated
Cd connection to kidney cancer [14–16], prostate cancer [15,
17, 18], cancer of testis [18], bladder cancer [19], breast cancer
[20], and overall cancer mortality [21].
The link between Cd exposure and PC development has
been extensively investigated as well, especially since the
pancreas is considered as an important organ for Cd accu-
mulation [22, 23]. Furthermore, many of known and well-
established risk factors of PC are connected to an increased
Cd body burden, that is, age and smoking. This review will
summarize, evaluate, and discuss information on Cd role
in PC development collected from available and recently
published observational studies,meta-analyses, experimental
animal, and in vitro studies.
2. Cd Role in PC Development-Human Studies
First authors to hypothesize that Cd exposure can cause PC
development were Schwartz and Reis [24]. They conducted
a meta-analysis of reports on the mortality of workers
exposed toCd.Their hypothesis that exposure toCd increases
the risk of death from PC was supported by the evidence
collected from three cohort studies included in this meta-
analysis [25–27].The same year, Ojaja¨rvi et al. [28] conducted
meta-analyses aiming to consolidate epidemiological data
on pancreatic cancer and various worksite exposures. This
study, however, did not provide evidence on Cd pancreatic
carcinogenicity.
In next few years, studies in population without occu-
pational exposure history, that is, general population, were
conducted with the aim of collecting epidemiological evi-
dence that Cd is a potential human pancreatic carcinogen.
Li et al. [29] carried out a prospective study in a general
Japanese population between 45 and 74 years of age. Dietary
Cd intake was estimated through questionnaires and during
next nine years cancer development was followed. There was
no evidence of an association between cancer development
and Cd intake in this study. Analysis of data collected from
Third National Health and Nutritional Examination Survey
(NHANES III) cohort showed an association between Cd
exposure, independent of cigarette smoking, and mortality
from PC, but the Cd-cancer association was only observed
in males [30]. These results add to evidence of Cd exposure
as a possible cause of PC is independent of smoking. In
a case-control study conducted in Spain to determine the
relationship between PC risk and trace elements levels,
toenail samples of PC cases and hospital controls were used
to determine levels of different trace elements among other
Cd. The results of the study confirmed Cd role in pancreatic
cancer risk [31]. Luckett et al. [32] showed evidence of
an etiological link between Cd exposure and PC in the
population of South Louisiana, USA, which has the history
of PC that exceeded the national average. The Cajun popu-
lation, especially the older cohort investigated in this study,
consume large amounts of seafood, rice, and pork which are
important sources of Cd, possibly increasing their exposure
to Cd. One mechanism through which Cd could promote
PC increased synthesis of metallothionein since positive
staining for metallothionein in pancreatic carcinomas was
often associated with worse histological grade of carcinoma,
liver metastases, and shorter survival as shown by Ohshio et
al. [33] in a sample of 75 pancreatic duct cell carcinomas.
Environmental exposure to Cd among inhabitants living
in the Cd-polluted Kakehashi River basin in Japan showed
no significant increase for malignant neoplasm mortalities
(including PC). Garcia-Esquinas et al. [34] examined the
association between the long-term Cd exposure as measured
in urine and cancer mortality in Native Americans partici-
pating in the Strong Heart Study (a prospective cohort study
with a follow-up of 20 years). The authors found prospective
association between low-to-moderate Cd exposure and total
cancer mortality and mortality from lung and PC. Similar
to Adams et al. [30], after adjusting for smoking status,
authors account Cd, an independent risk factor for PC. In
a meta-analysis that included the studies listed above [29–
32, 34, 35], the authors found a positive association between
Cd exposure and the increased risk of PC in males, while no
significance was observed in females [36]. This phenomenon
was clarified with the hypothesis that steroid hormones can
have a protective role in the development of pancreatic cancer
and that women tend to consume more vegetables and fruits,
that is, more antioxidants and fiber [37, 38]. One more study
attempted to establish a correlation between environmental
exposure to Cd and PC development. In a pilot study, Kriegel
et al. [39] tested the hypothesis that PC patients in East Nile
Delta region of Egypt (a region with high incidence of early-
onset pancreatic patients) were exposed to higher levels of
Cd than the subjects with no PC diagnosis. A significant
association between PC and serum Cd levels was confirmed,
once again proving Cd as an independent risk factor for PC.
Summarized cohort and case-control observational stud-
ies represent an expanding body of evidence that Cd is a
risk factor for PC development even as a factor independent
of smoking and occupational exposure, particularly in man.
Nevertheless, Cd exact role in PC carcinogenesis is still
unknown. Our recent investigations pointed to the direct
role of Cd in PC development. Namely, in our pilot case-
control study, concentrations of Cd were significantly higher
in human PC tissue than in control pancreatic tissue [40].
Furthermore, tissue concentrations of Cd in tissue surround-
ing tumor were still significantly higher than in control
tissue [41]. However, understanding the role of Cd in the
PC development is possible only through additional work
that will provide solid evidence of this association under the
experimental conditions and give better insight into cellular
and molecular changes that are happening in pancreatic cells
under the Cd influence.
BioMed Research International 3
3. Cd Role in PC Development-Animal Studies
Cadmium is a complete carcinogen in experimental animals;
it has proven to effectively induce cancers at multiple sites,
by various routes of exposure and doses. Inhalation in rats
induces pulmonary adenocarcinomas, ingestion or injection
can induce tumors and preneoplastic lesions within the rat
prostate, and at the site of subcutaneous (s.c.) or intramus-
cular (i.m.) injections Cd can produce local mesenchymal
tumors. Other targets of cadmium in rodents include the
liver, adrenal, pituitary glands, hematopoietic system, and
pancreas [14, 42, 43].
Carcinogenic effects of Cd in the animal pancreas are very
complex. As reviewed by Waalkes et al. [44], Cd impact on
the incidence of tumors in the rat pancreas was dependent
on the conditions of exposure. When Cd is administrated via
s.c. route, it induces a dose-related reduction in pancreatic
tumor formation inWistar rats.When given via s.c. injection,
but concurrently with calcium-induced islet cell tumors of
the rat, multiple s.c. injections of Cd in Wistar and Fischer
rats resulted in transdifferentiation of pancreatic cells into
hepatocytes. In fact, Cd is one of the most potent agents
known to induce transdifferentiation, that is, metaplasia
of the pancreatic cells [44, 45], and since the process of
metaplasia involves cellular dedifferentiation, proliferation,
and redifferentiation, it may increase the risk for neoplasia
[46].
Due to lack of an apparent biological mechanism for
excretion,Cd accumulates in tissues, with the largest amounts
deposited in kidneys (half-life in the cortex is 10 to 30
years) and liver, followed by the pancreas and lungs [5].
Our recent findings also confirmed Cd deposition in the
pancreas, as single oral doses of 15 and 30mg Cd/kg b.w.
produced significantly higher levels of Cd in pancreatic tissue
of Wistar rats when compared to untreated controls 24 h
after administration (unpublished data). Furthermore, oral
doses of 5mg CdCl
2
/kg b.w. given over 4 weeks resulted in
increased Cd concentrations in the pancreas of rats when
compared to controls [47].
Potential mechanisms of Cd carcinogenicity in animals
have been suggested by Schwartz and Reis [24]. According to
the authors, substitution ofCdwith zinc (Zn)may be a central
mechanismunderlyingCd carcinogenicity. Zn is known to be
essential for DNA, RNA, and protein synthesis, that is, for cell
division, and pancreas contains high levels of Zn. Evidence of
Cd effects on Zn homeostasis was reviewed by Matovic´ et al.
[6] and Brzo´ska and Moniuszko-Jakoniuk [48]. Recently, we
demonstrated these Cd interactions with Zn in the pancreas
of rabbits [49, 50]. Further illustration of the importance of
Cd-Zn interactions in PC development is that the effects of
Cd on several organs [51] and even tumor formation [52] can
be suppressed by the simultaneous Zn treatment. Another
possible mechanism of Cd carcinogenicity assumed by the
same authors [24] is the ability of Cd to inducemitogenesis in
pancreatic cells as reflected by the increased metallothionein
synthesis to which Cd is highly bound in the pancreas of rats.
Other studies conducted on animals revealed different
toxic effects of Cd on pancreas and mechanisms of these
effects that could explain Cd carcinogenicity in the pancreas.
One well-established general mechanism of Cd toxicity is
oxidative stress induction as reviewed in our recent papers
[6, 7]. Cadmium ability to produce oxidative stress was
shown in the pancreas of rats treated with 5mg CdCl
2
/kg
b.w. during 4 weeks [47]. Levels of reactive oxygen species
and lipid peroxidation in the pancreas of Cd-intoxicated
animals were significantly higher than in controls, while
levels of various antioxidant enzymes were significantly
decreased as compared to those of the controls, suggesting
cellular oxidative stress-mediated toxicity. In another study
conducted on mice, an interesting mechanism by which Cd
produces pancreatic toxicity and potential carcinogenicity
was introduced. A single s.c. injection of 1mg Cd/kg to mice
had no obvious toxic effects on pancreas at either 1 or 5
days after Cd treatment. Withal, the activities of pancreatic
proteases trypsin, chymotrypsin, and carboxypeptidase A
were significantly decreased at 1 day after treatment, while
the activity of carboxypeptidase B was not changed. These
changes in enzymatic activity returned to control levels 5 days
after Cd treatment, which suggests that Cd-mediated effects
could be reversible. Bearing in mind the complex roles of
these enzymes within the organism, the inhibition of these
enzymes may have an impact on various critical physiolog-
ical functions, among which cellular transdifferentiations in
pancreas and cancers can be assumed [53].
From in vivo studies, both in humans and in rodents,
there is evidence that suggests the role of Cd in the devel-
opment of PC through cellular changes involving oxida-
tive stress, changes in apoptotic pathways, and epigenetic
changes. Human studies tend to involve post hoc observation
and the description of Cd-mediated toxicity in the pancreas
[54], renal tubule [55], and liver [56]. Human studies have
been extended to include nonhuman species, such as mouse
and livestock [53, 57]. Many of these organ deficits have been
attributed to the actions of Cd and its ability to increase the
generation of free radicals, alter cellular apoptosis [54], and
promote epigenetic changes [58]. Collectively, it is apparent
that in vitro studies will be needed to augment findings in
vivo. The use of in vitro analysis will permit investigators to
probe the cellular changes that occur following Cd exposure,
which lead to altered pancreatic function and the develop-
ment of PC.
4. Cd Role in PC
Development-In Vitro Studies
An important tool for studying the carcinogenic actions of Cd
is the development of an appropriate in vitro model [59, 60].
Utilizing a combination of in vivo and in vitro data, other
investigators have attempted to describe the carcinogenic
action of Cd from an intracellular perspective [15, 61]. To
date, data from in vitro studies have been difficult to interpret.
Many investigators report only the positive effects following
Cd exposure while using excessive concentrations of Cd,
which would skew data interpretation [43]. There have been
excellent reviews that focused on the generalized role of Cd
as a carcinogenic agent [24, 42, 43, 62]. Model systems for the
study of Cd-mediated carcinogenic effects are limited, and
model systems for the study of PC are even fewer. Multiple
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studies have linked Cd-mediated effects to the development
of PC or hypothesized that Cd could be involved in PC devel-
opment [15, 24, 31, 32, 39, 40, 63].Human studies have shown
that Cd concentrations are approximately 5 times higher in
tissue that is obtained directly from a pancreatic tumor when
compared to Cd concentrations found in control/non-PC
tissue [40]. Even tissue near the tumor displayed significantly
higher Cd concentrations when compared to control tissue
[40]. In vitro studies which substantiate human in vivo
studies have been equivocal in their findings. From the
current literature, Cd-mediated effects may be via (1) reactive
oxygen species (ROS)/free radicals or oxidative stress, (2)
changes in apoptotic pathways, (3) epigenetic changes, or (4)
a combination of effects viamultiple pathways. Collectively, it
is clear that delineating the mechanisms of Cd in promoting
the development of PC will be time-consuming.
Oxidative stress or the generation of reactive oxygen
species (ROS, free radicals) appears to have an impact on the
development of PC or generalized damage to the pancreas.
There have been relatively few studies associated with Cd-
induced oxidative stress in the pancreas. There have been
numerous reports demonstrating Cd bioaccumulation in
the pancreas [24, 31, 32, 34, 39, 40, 42, 43, 59]. Cadmium is
considered a redox-inactive cation, and its primary mode
of toxicity is through zinc finger or sulfhydryl binding
[64]. Inflammation following oxidative stress, a precursor
for potential tumor development, is an underlying cause of
pancreatitis [65–67]. There are many reports and reviews
demonstrating ROS-mediated toxicity associated with Cd
exposure [68, 69]. Studies showing Cd-mediated oxidative
stress have utilized multiple cells lines or in vitro model
systems [70–72]. Determination of the specificity of Cd-
mediated cellular damage requires addressing the question
of whether the effects are direct or indirect. Exposure to
particular environmental pollutants will induce oxidative
stress, and the generation of free radicals will kill some cells,
but in the surviving cells, apoptosis will be initiated to attempt
cellular repair [73]. In neuronal cultures, Cd induces the
formation of free radicals which result in cellular damage
but also trigger the activation of the mTOR pathway leading
to cellular death [69]. The neuronal culture findings are
supported by at least one study in pancreatic 𝛽-cells that
suggests that Cd-mediated damage to 𝛽-cells is initiated by
oxidative stress which reduces the density of 𝛽-cells, followed
by mitochondrial-induced initiation of apoptosis [74]. When
all of the evidence is taken together, it does appear that
oxidative stress is involved in the development of PC. This
involvementmay be via an indirect mechanism, such as caus-
ing the inflammation which leads to the development of PC
following the release of inflammatory mediators. Additional
work needs to be performed to further our understanding of
the molecular and intracellular actions of Cd.
The regulation or dysregulation of apoptotic pathways by
Cd is particularly intriguing. Cdmay elicit indirect actions on
apoptosis (as through oxidative stress discussed previously)
or through direct actions on apoptotic regulatory proteins
[75]. Like mercury, Cd in its divalent form has been shown
to interact with zinc-binding sites and thiol groups that are
commonly found in proteins [15]. Interestingly, Cd-mediated
effects on apoptotic pathways are as unclear as what is
observed for Cd-mediated oxidative stress. The cell type
that is exposed to Cd seems to be an important factor [61].
A previous study demonstrated Cd-induced apoptotic in
pancreatic𝛽-cells that were secondary to oxidative stress [74].
The process of normal apoptosis is necessary to maintain
the integrity of the cells. During apoptosis, repairs are
attempted on damaged cells, and if the damage is irreparable,
the cells are eliminated maintaining cellular integrity. If
cell growth is permitted unfettered, an increased number
of mutated/damaged cells will be allowed to proliferate.
Conversely, if cell growth is reduced to an excessive number
of cells entering apoptosis, this too will be detrimental to
cellular integrity [43, 62]. One mechanism for Cd-induced
apoptotic inhibition is through suppression of caspase activ-
ity. This hypothesis is supported by data that suggest either
caspase-3 or caspase-7 inhibition followingCd exposure [46].
Inhibition of caspase would reduce the number of cells in
apoptosis resulting in an increased proliferation of defective
cells. The tumor suppressor protein, p53, has been a target of
investigation by numerous laboratories. The results for Cd-
mediated alterations in p53 activity have not been clear. In
prostate cells, Cd induces p53 activity, which would suggest
tumor suppression [76]. Resistance will develop to elevated
p53 activity resulting in tolerance to the tumor-suppressive
activity of p53. Contrary to prostate cell data, Cd decreases
p53 activity and increases cellular proliferation in zebrafish
liver cells [75]. Increased activation of tumor-promoting
oncogenes will lead to an increased risk for PC [77]. Cad-
mium exposure reported can increase the activity of the K-
ras oncogene, leading to increased tumor formation [78].
In immortalized control pancreatic cells [HPNE (Human
Pancreatic epithelial Nestin-Expressing)], K-ras activation
increased signaling in PI3K/Akt and ERK1/2 pathways as well
as TGF𝛼 signaling and is involved in PC formation [79].
Also, p38/MAPK pathway activation is involved in observed
p16 upregulation which also increases [79]. Cadmium has
been reported to interact with Zn, interfering with DNA
repair proteins [15, 62, 76, 80]. Molecular changes in the
3-dimensions structure of the apoptotic proteins will affect
the cells ability to repair cellular injury which will result in
uncontrolled cellular growth that perpetuates the damage
associated with the modified cells. It is apparent that Cd-
mediated effects on apoptosis are highly dependent on the
(1) type of exposure: in vitro versus in vivo, (2) cell or organ
type, (3) gender, (4) Cd concentration, and (5) the point in the
apoptotic pathway being investigated. Therefore, caution is
needed in planning in vitro studies examining Cd-mediated
changes in apoptosis.
Epigenesis, as it relates to genetic changes (epigenetics),
is defined as gene alterations in response to influences, such
as environmental/occupational insults which could impact
the expression of genetic material in either a positive or
negative way. To date, no studies have intensively studied
the epigenetic role of Cd in the development of PC. Prenatal
exposure to Cd during embryogenesis appears to involve
changes in DNA methylation [81, 82]. The authors acknowl-
edge that many of the existing studies have extrapolated
epigenetic changes following exposure to high concentrations
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of Cd and that these interpretations may be skewed [81].
An increasing number of studies have examined the effects
of various pollutants, including Cd, on epigenetic changes
in adults [83–86]. Multiple investigators have reported that
Cd is a carcinogen, but weakly mutagenic [43, 61, 84, 85].
The current theory suggests that Cd can act epigenetically
through several molecular mechanisms: (1) interruption of
DNMT activity, (2) interference with DNA repair mech-
anism, or (3) miRNA upregulation. Studies have shown
plasticity in cadmium reactivity by demonstrating its initial
association with global hypomethylation at several promoter
sites, followed by consequent hypermethylation, indicating
restored viability after 8 hours of exposure [87]. Martinez-
Zamudio and Ha [85] have examined the literature to deter-
mine whether or not Cd-mediated epigenetic changes could
be inheritable. The results were inconclusive and suggested
that more work would be needed to better understand
the inheritable potential of genetic changes following Cd
exposure. In lung fibroblast cells, Cd exposure resulted in
an increased in DNA methylation of p16 and an upregu-
lation of DNMT3b [84]. The duration of exposure to Cd
seems to significantly affect the methylation process, with
acute Cd exposure resulting in hypomethylation, followed
by hypermethylation after chronic exposure [82, 85]. Con-
sidering the long biological half-life exhibited by Cd, even
acute exposures would be “chronic” exposure due to the
extended duration of the body burden. In vitro Cd exposure
has been shown to increase marker expression related to
the conversion of noncancer stem cell for cancer stem
cell populations in both breast and liver cancer cell lines
[83]. Increased levels of p-Ras, p-Raf-1, p-MEK-1, and p-
ERK-1 protein were observed in suggesting an increase in
the Ras signaling cascade [83]. The c-fos protooncogene
is upregulated by Cd exposure and consequently interferes
and suppresses the p53 tumor suppression mechanism [24].
Cd’s ability to replace zinc in the zinc finger structure
of xeroderma pigmentosum A protein prohibits cells from
removing lesions on the DNA helix, blocking transcription,
and translation [80]. It is also possible that Cd recruits
transcription factors usually recruited by zinc, increasing
mitogenesis and propagating the replication of damaged
DNA [43]. The final potential epigenetic mechanism influ-
enced by cadmium exposure manifests in increased miRNA
production. Aberrant expression ofmiRNA fragments results
in epigenetic transcriptional regulation. For example, recent
studies have indicated an upregulation of miRNA 146 expres-
sion in steel workers exposed to Cd inhalants. miRNA 146
is associated with nuclear factor kappa-B, with links to
carcinogenesis and inflammatory response [88]. Recent work
has examined the epigenetic role of Cd in the development
of various cancers such as melanoma [89], gastrointestinal
tract [90], and uterine-endometrial carcinomas [91]. Across
each specific cancer, the key epigenetic events that transpired
were increased DNA methylation, increased expression,
and production of either pro- or antiapoptotic proteins,
such as DNMTs, p53, p16, and other proinflammatory pro-
teins [89–91]. Currently, there have been no studies which
focused solely on epigenetic changes due to Cd exposure in
PC.
Collectively, in vitro studies have yielded a confusing
landscape to date. It is apparent that a considerable amount
of work is still needed to understand further the cellular and
molecular pathways that are altered following Cd exposure.
The current literature would suggest that Cd is not directly
genotoxic but instead may directly or indirectly increase
oxidative stress and the formation of DNA- and protein-
damaging free radicals. Cd has also been shown to alter
cellular ability to enter apoptosis and perform cellular repair.
Changes in apoptosis could also lead to epigenetic changes
due to damaged andmutatedDNA. In vitro investigation into
Cd’s role in the development of PC will be a dynamic and
evolving area of research for many years to come.
5. Summary
Although interest in Cd as a potential carcinogen has risen
dramatically in the last two decades, more work must be
done to further our understanding of Cd-mediated toxic
mechanisms. Mounting evidence suggests that Cd exposure
is a major health concern and the ability that Cd displays to
bioaccumulate and to remain persistent in the environment
for years further compounds the dangers associated with Cd
exposure. An increasing number of human and experimental
clinical studies are specifically investigating the effects of Cd
on the pancreas. Yet, the data is somewhat conflicting, but
more evidence points towards Cd as an agent responsible for
the development of PC. When the in vivo data is used as a
foundation for in vitro studies, there is an increasing body of
evidence that outlines the toxic mechanisms associated with
Cd exposure. Although multiple mechanisms are proposed,
the three predominant toxic mechanisms are (1) alterations
in the redox status of the cell and generation of free radicals,
(2) changes in the apoptotic pathways necessary for normal
cell survival, and (3) epigenetic changes that would interfere
with the proper and vital functioning of DNA and RNA.
Significantly more work needs to be done to expand our
knowledge of the Cd-induced modifications in the pancreas
that promote the pathogenesis of PC.
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